Quorum Health (QHC) Receives Media Impact Score of 0.34

Press coverage about Quorum Health (NYSE:QHC) has trended positive on Thursday, Accern Sentiment Analysis reports. Accern ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Quorum Health earned a media sentiment score of 0.34 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 44.2797200454034 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Shares of Quorum Health (QHC) traded up $0.04 during mid-day trading on Thursday, hitting $6.74. The company had a trading volume of 95,000 shares, compared to its average volume of 190,882. The company has a current ratio of 1.84, a quick ratio of 1.68 and a debt-to-equity ratio of 9.39. Quorum Health has a twelve month low of $2.54 and a twelve month high of $9.37. The company has a market cap of $202.99, a P/E ratio of -1.07 and a beta of 7.19.

Quorum Health (NYSE:QHC) last announced its quarterly earnings data on Wednesday, November 8th. The company reported ($0.58) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.31). Quorum Health had a negative return on equity of 38.34% and a negative net margin of 8.28%. analysts anticipate that Quorum Health will post -1.78 EPS for the current year.

Several brokerages recently weighed in on QHC. Zacks Investment Research upgraded Quorum Health from a “sell” rating to a “hold” rating in a research report on Thursday. Morgan Stanley upgraded Quorum Health from an “underweight” rating to an “equal weight” rating and set a $3.00 price objective for the company in a research report on Wednesday, December 20th. Finally, Royal Bank of Canada restated a “hold” rating and set a $5.00 price objective on shares of Quorum Health in a research report on Tuesday, October 3rd. Two analysts have rated the stock with a sell rating and five have assigned a hold rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $4.13.

In other news, SVP Shaheed Koury bought 10,000 shares of the company’s stock in a transaction on Monday, November 13th. The stock was purchased at an average cost of $4.69 per share, for a total transaction of $46,900.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 4.70% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION WARNING: “Quorum Health (QHC) Receives Media Impact Score of 0.34” was posted by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://stocknewstimes.com/2018/01/18/quorum-health-qhc-receives-media-impact-score-of-0-34.html.

Quorum Health Company Profile

Quorum Health Corporation is an operator and manager of general acute care hospitals and outpatient services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR).

Insider Buying and Selling by Quarter for Quorum Health (NYSE:QHC)

Receive News & Ratings for Quorum Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quorum Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply